Differences in Pain Processing Between Men and Women
Study Details
Study Description
Brief Summary
Many chronic pain conditions show clear differences between between men and women, such as reported pain intensities or treatment effects, with chronic pain conditions being generally more frequent in women. Yet, the underlying mechanisms causing these differences are poorly understood. Central sensitization (CS) is considered one important mechanism in pain patients which differs between female and male patients. The central hypothesis is that already in the healthy population CS processes are more pronounced in women than in men.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Experimental Arm
|
Other: Cutaneous thermal stimuli
Application of thermal stimuli of different intensities to the skin
|
Outcome Measures
Primary Outcome Measures
- Change in spatial extent of mechanical hypersensitivity after intervention w.r.t. baseline [10-20 minutes before intervention (baseline) and 20-30 minutes after intervention]
Mapping of hypersensitivity in cm2 of sensitized skin area using two quantitative sensory testing tools (256mN von Frey filament and 200-400mN brush) before and after intervention
- Changes to the nociceptive withdrawal reflex (NWR) after intervention w.r.t. baseline [5-10 minutes before intervention (baseline) and 30-35 minutes after intervention]
Repetitive suprathreshold elicitation of the NWR to monitor its characteristics (such as magnitude and number of responses) before and after intervention
Eligibility Criteria
Criteria
Inclusion Criteria:
-
good general health
-
able to give informed consent
Exclusion Criteria:
-
pain complaints for more than two consecutive days over the past three months
-
any major medical or psychiatric condition (e.g. heart disease, major depressive disorder)
-
any chronic pain condition
-
inability to follow study instructions
-
consumption of stimulants, drugs, or analgesics within the past 24 hours
-
scar tissue or generally reduced sensitivity in the designated testing site areas
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Balgrist Campus | Zürich | Switzerland | 8008 |
Sponsors and Collaborators
- Balgrist University Hospital
Investigators
- Principal Investigator: Petra Schweinhardt, MD, PhD, Department of Chiropractic Medicine, Balgrist University Hospital, University of Zurich
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NWR